Bavarian Nordic A/S (OTCMKTS:BVNRY) Sees Large Growth in Short Interest

Bavarian Nordic A/S (OTCMKTS:BVNRY) saw a large growth in short interest in February. As of February 15th, there was short interest totalling 5,300 shares, a growth of 55.9% from the January 31st total of 3,400 shares. Based on an average daily trading volume, of 24,500 shares, the short-interest ratio is currently 0.2 days.

Bavarian Nordic A/S Trading Down 0.5 %

Shares of OTCMKTS BVNRY opened at $7.68 on Tuesday. The stock has a 50-day moving average price of $8.58 and a two-hundred day moving average price of $9.98. Bavarian Nordic A/S has a 12 month low of $6.86 and a 12 month high of $14.60. The company has a market cap of $1.82 billion, a price-to-earnings ratio of 11.13 and a beta of 1.68.

About Bavarian Nordic A/S

Bavarian Nordic A/S develops, manufactures, and commercializes life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-borne encephalitis vaccine under the Encepur name; and Ebola vaccine under the MVABEA name.